“Aman Gupta Dives Deep into Wellness with Zingavita Ayurveda Founders on Shark Tank India 4”

“Aman Gupta Dives Deep into Wellness with Zingavita Ayurveda Founders on Shark Tank India 4”



Zingavita Ayurveda: Redefining Wellness with Shilajit Products on Shark Tank India Season 4

Zingavita Ayurveda: A New Era of Shilajit Products on Shark Tank India Season 4

Shilajit wellness products are gaining traction as Shark Tank India season 4 showcases innovative ideas and intense negotiations. On the 7th of March, entrepreneurs Dheeraj Nagpal and Sachin Goel from Chandigarh took the stage to present their unique venture, Zingavita Ayurveda, with the aim of transforming perceptions surrounding Shilajit-based wellness offerings.

During their presentation, they unveiled a range of products, which included pure Himalayan Shilajit, Shilajit honey, effervescent tablets in various flavours, and coffee. Their objective was to dispel the notion that Shilajit is solely associated with men’s sexual wellness. They requested an investment of ₹1 crore for 1.25% equity in their burgeoning company.

Located in Gurugram, Zingavita aims to bridge traditional Ayurveda with modern nutritional science. Their lineup features high-quality supplements, including pure Himalayan Shilajit and various Shilajit-infused products such as resin, effervescent tablets in flavours like elaychi and cola, along with honey and coffee. These products are designed to support health and fitness among users.

As the sharks reviewed the offerings, Ritesh Agarwal was the first to raise issues regarding the premium pricing. Vineeta Singh asked about the consumption patterns of the products, while Aman Gupta humorously pointed out the inclusivity of Shilajit in their products by saying, “Aap ne sab Shilajit banaye hain, Shilajit, Shilajit…” (You’ve made everything from Shilajit). He jokingly declined to taste the Shilajit honey, stating, “Ye humein nahi zaroorat” (I don’t need this).

The founders defended their business model by highlighting the successful adoption of their product in the US market, citing this as evidence of increasing demand within India. Nevertheless, Namita Thapar expressed disappointment over the absence of clinical testing backing their claims. Kunal Bahl forthrightly commented, “Aapko lagta hain ye saman bik raha hai market mein toh hum bhi bech le” (So you thought since the product is selling in the market, let us also sell the same product).

Despite the entrepreneurs’ enthusiasm and detailed pitch, their efforts did not persuade the sharks to invest, resulting in them leaving without securing a deal.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.